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Abstract
Dendritic cells comprise a complex array of cell populations that play a leading role in 
immune defense. In an immature state, they have the capacity to sense and uptake dif-
ferent antigens. Upon capturing antigens, they become activated, mature, and migrate to 
lymph nodes where they present antigen-derived peptides to naïve T cells. Due to these 
excellent surveillance properties, dendritic cells play an important role against parasitic 
infections. Also, dendritic cells are an important source of IL-12, which is a fundamental 
proinflammatory cytokine in the control of intracellular parasites. The aim of this chapter 
is to review the most important characteristics and functions of dendritic cells and their 
role in the control of infection by parasites.
Keywords: dendritic cells, pattern recognition receptors, pathogen-associated molecular 
patterns, protozoan parasites
1. Introduction
1.1. Generalities of dendritic cells (DC)
Dendritic cells (DC) were discovered by Paul Langerhans in 1868 when he described den-
dritic, nonpigmentary cells in the epidermis that he considered intraepidermal receptors for 
extracutaneous signals of the nervous system [1]. Afterwards, Langerhans discovery fell into 
oblivion and almost 100 years elapsed until, in 1973, Steinman and Cohn described a cell 
population in the spleen of mice similar to the one described by Langerhans that had appear-
ance and behavior different from monocytes and macrophages and were named as dendritic 
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cells [2]. They observed that this new cell population had a great capacity to initiate and 
modulate the immune response [3, 4] and expressed high levels of MHC-II and CD11c [5, 6].
Currently, DC are recognized as a heterogenous cell population whose members differ in 
ontogeny, anatomic localization, migration, and due to the great repertoire of functions they 
perform, make them key participants in the immune response. DC are localized in lymphoid 
and nonlymphoid tissues including blood. At the periphery, they capture antigens through 
the recognition of pathogen-associated molecular patterns (PAMPs) by PAMPs recognition 
receptors (PRRs), migrate, and transport them to lymphoid organs where they are specialized 
in antigen processing and efficiently present endogenous and exogenous antigen-derived pep-
tides in both MHCI and MHCII contexts. DC also have the unique capacity of presenting exog-
enous noncytosolic antigen-derived peptides in the context of MHCI by cross presentation [7], 
a critical mechanism for the immune response against viruses and intracellular bacteria [8]. In 
addition to the primordial role of DC in antigen processing and presentation, their participa-
tion has been broadly documented, along with other immune cells, in the production of cyto-
kines that modulate the immune response toward a Th1 or Th2 response, in the regulation of 
cytotoxic T lymphocytes, and in immunologic tolerance [9–15]. The crucial role of DCs in the 
initiation and regulation of adaptive immunity has led to their use in dendritic cell-targeted 
vaccination [16]. It has been documented that following loading with pathogenic antigens 
and adoptive transfer, DC mediate protection against a wide spectrum of infectious diseases 
[17–19]. However, it has been shown that the employment of ex vivo antigen-loaded DC for 
first-line prophylactic vaccination is not adequate. Targeting dendritic cells in situ through 
antigen-DC receptors has circumvented this obstacle. Indeed, this new strategy has proven to 
be effective against different infections, including parasitic infections [20] and can be explained 
by the facility of exposing antigens to DC and their regulated presentation pathways. The out-
come of these studies emphasizes that targeted delivery of antigens to DC surface endocytosis 
receptors such as C-type lectins increases antibody and cell-mediated immunity [21].
Due to their complexity, the establishment of the origin of DC and their classification has 
encountered some difficulties; nevertheless, researchers have reached a consensus on these 
topics, which is discussed next.
1.2. Origin and subpopulations of DC
The origin of DC has been more precisely deciphered in the murine model as compared to 
humans. It has been established that during their differentiation, hematopoietic precursors 
CD34+ in the bone marrow give rise to common myeloid progenitors (CMP) characterized for 
the expression of Lin− CXCR1+ CD11b− cKit+ CD135+ [22]. These CMP give rise to the common 
progenitor of monocytes and dendritic cells (MDP) [9, 15, 23, 24], which in turn originate the 
precursors of plasmacytoid DC (pre-pDC) and conventional DC (pre-cDC). These cells aban-
don the bone marrow to the circulation to later colonize the tissues as immature DC where 
they develop and differentiate to DC [23, 25–29]. It has been shown that the growth factor 
FMS-like tyrosine kinase 3 ligand (Flt3L) [30–32] is essential for the process of differentiation 
of mouse DC, while M-CSF and GM-CSF are indispensable for the development of progeni-
tors, but not for their maturation [33].
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In relation to the origin of human DC, for years it has been difficult to establish their ontogenic 
pattern. Nevertheless, the culturing of human hematopoietic stem cells CD34+ performed by 
Lee and colleagues [34] shed important information about their origin. They showed that 
these precursors give rise to the human progenitor of granulocytes, monocytes, and DC 
(hGMDP), which in turn originate the progenitor of human DC and monocytes (hMDP). The 
hMDP gives rise to monocytes and the common progenitor of DC (hCDP). Differently from 
GMP (granulocytes and macrophages progenitor), hCDP are found not only in cord blood 
and bone marrow, but also in peripheral blood and lymphoid tissues and originate the differ-
ent types of DC [34]. These cells are characterized for a high expression of MHCII, but lack the 
typical markers of CD3 lineage (T lymphocytes), CD19/20 (B lymphocytes), and CD56 (NK 
cells), reason why DC have been traditionally named as HLA-DR+ lineage−-cells. There are 
two principal subtypes of DC: conventional DC (cDC), also called myeloid DC (mDC), and 
plasmacytoid DC (pDC) [15].
1.2.1. Conventional (cDC) or myeloid DC (mDC)
cDC or mDC share an ontogenical origin with monocytes and macrophages, and thus, GM-CSF 
is essential for their differentiation in vitro. These cells are characterized for the expression of 
typical myeloid antigens such as CD11c, CD13, CD33, and CD11b. CD11c is also expressed in 
human cDC and monocytes, but cDC lack CD14 or CD16 and may be subdivided into cDC 
CD1c+ and cDC CD141+ fractions. These two fractions share homology with mouse classical DC 
expressing either CD11b (CD1c+ DC) or CD8/CD103 (CD141+ DCs) [35]. cDC are also character-
ized for the expression of different Toll-like receptors (TLR) such as TLR1, TLR2, TLR3, TLR4, 
TLR5, TLR6, TLR7, TLR8, and TLR10 [36]. Additionally, human mDC have been subdivided 
according to their anatomical localization into three groups: (1) peripheral tissue-resident, 
(2) secondary lymphoid organ-resident, and (3) circulating blood mDC [35]. In particular, 
peripheral tissue resident DC encompass different mDC subsets localized in human skin. 
These include Langerhans cells (LC) and dermal interstitial DC (intDC). The origin of these 
two cell populations is still controversial, since some authors suggest that the precursor is of 
myeloid origin and one of the intermediaries is the monocyte [37]. Contrarily, other authors 
have proposed that the origin of LC and intDC proceeds from a fetal progenitor that also origi-
nates the glia in the central nervous system [38]. LC are localized in the epidermis and express 
CD1a, langerin, and E-cadherin. intDCs are localized in the dermis and express DC-SIGN, 
CD11b, XIIIa factor, and CD14. Besides, these cell populations differ in the response to cer-
tain stimuli and production of cytokines and chemokines. For example, the stimulation with 
CD40L induces the production of IL-10 by intDCs, but not by LC. On the other hand, intDCs 
produce IL-6 and IL-12 that induce the differentiation of B cells toward IgM-producing plasma 
cells and stimulate Th cells for the production of Th1 cytokines, favoring this type of response. 
LC stimulate Th cells for the secretion of IL-4, IL-5, and IL-13, resulting in a Th2 response [35].
1.2.2. Plasmacytoid dendritic cells (pDC)
These cells owe their name to their similar appearance to plasma cells and to the fact that they 
proceed from a lymphoid progenitor, reason why they require IL-3 instead of GM-CSF for 
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their differentiation in vitro. pDC are characterized for the production of type I IFN in response 
to viral recognition through TLR7 and TLR9. Apart from these TLR, they also express TLR1 
and TLR10 [36]. In mice, pDC are localized in bone marrow, blood, and lymphoid organs 
and are characterized for the expression of CD11c, CD45RA, CD317, and CD172 with a low 
expression of MHCII and negative for CD11b. They also show a significant expression of 
Ly6C, Ly49Q, and Siglec-H [39–41]. It has been shown that mouse pDC are not as efficient in 
antigen presentation and T cell priming as cDC, even when activated. Instead, murine pDC 
participate in peripheral tolerance through the induction of regulatory T cells (T regs), which 
has been proposed to occur by two mechanisms. In one case, it has been suggested that T 
regs are generated via the production of IDO and subsequent T cell tryptophan starvation 
upon CD200R engagement. On the other hand, the suggestion is that T regs generation is 
dependent on IL-10 and TGF-β production by pDC. Other studies have also demonstrated 
that pDC induce T cell anergy or deletion [42–44]. In relation to human pDC, it has been 
established that they are strong activators of T cells and share the capacity of their murine 
counterparts to induce tolerance. Some characteristic markers of human pDC are BDCA-2 
(CD303), BDCA-4 (CD304), CD123hi, and CD1clow (BDAC-1) [41], and they have been divided 
into two populations based on CD2 expression [45]. Both pDC subsets demonstrate strong 
activation and cytokine production in response to viruses, but CD2hi pDC express IL-12p40 
during influenza infection, are better stimulators of naïve T cells, and have a better survival 
rate in response to stress and glucocorticoid treatments [46–48].
1.2.3. Dendritic cells that respond to specific microorganisms: tip-DC
It has been shown that some populations of DC develop in response to specific microorgan-
isms. Such is the case of Tip-DC (CD11bint, CD11cint, Gr-1+, DEC-205−, CD14−, F4/80−) that 
produce TNF and iNOS/NO upon the infection with some microorganisms such as Listeria 
monocytogenes and Brucella melitensis, which results in an effective mechanism against infection. 
Nevertheless, in some cases, this response has been associated with tissue damage [49–51].
It has also been demonstrated that during infection with the intracellular parasite Trypanosoma 
brucei, tip-DC represent the major pathogenic M1 liver subpopulation. CD11b+ Ly6C+ mono-
cytic cells migrate from bone marrow to the liver of infected mice through CCR2 interac-
tions, then differentiate to immature inflammatory DC (CD11c+ CD80/CD86/MHC-IIlow) 
in an IFN-γ and MyD88 signaling-independent, and finally mature to functional Tip-DC, 
whose signaling depends on IFN-γ and MyD88. Interestingly, IL-10 dampens Tip-DC func-
tion during T. brucei infection by limiting their differentiation and maturation and CCL2 
expression [52].
1.2.4. DC CD14+
DC CD14+ are a group of myeloid DC CD11c+ localized in diverse nonlymphoid tissues as 
well as in lymph nodes. They were originally described as interstitial DC and are character-
ized by the presence of CD14, which suggests that they probably originate from monocytes 
with which they share more features than with CD11c+ and CD141+ DC [35].
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1.2.5. Monocyte-derived dendritic cells (moDC)
As already mentioned, DC originate from precursors present in the bone marrow; neverthe-
less, some of them can differentiate from other cells, as is the case of moDC. In humans, there 
are three types of monocytes: classic (CD14+, CD16−), intermediate (CD14+, CD16+), and non-
classic (CD14low, CD16+). Currently, it has not been accurately defined from which monocyte 
subtype moDC derive in vivo [53]. According to transcriptomic analysis, it has been suggested 
that in humans, skin DC CD14+ as well as DC CD103− CD172a+ from intestine are related to 
monocytes [54, 55], reason why they are considered authentic moDC. On the other hand, in 
inflamed tissues, inflammatory DC express CD11c+, CD1a+, and CD14+ that are most probably 
derived from monocytes and therefore are also considered moDC [56, 57].
DC are one of the most important effectors in the immune response due to the multiple func-
tions they play such as recognition of PAMPs and activation to produce proinflammatory 
and regulatory cytokines, phagocytosis of pathogenic organisms, migration to spots where 
danger and pathogenic signals exist, and processing and presentation of antigens through 
with MHCII and CD1 to T lymphocytes. In the next section, we will discuss the receptors 
present in dendritic cells that interact with pathogenic organisms [58].
2. Pattern recognition receptors (PRRs) present in dendritic cells
As already mentioned, DC are the surveillance cells that need to distinguish between self 
and nonself. They are able to recognize different molecules such as proteins, lipids, carbo-
hydrates, and nucleic acids of bacterial, viral, fungal, or protozoan origin known as PAMPs. 
To achieve this surveillance task, DC possess distinct types of receptors among, which are: 
Toll-like receptors (TLR), RIG-I-like receptors (RLR), NOD-like receptors (NLR), and C-type 
lectin receptors (CLR) [59].
2.1. Toll-like receptors (TLRs)
Innate immunity is the first line of host defense against pathogen infection, and infected 
hosts need to detect the invasion of pathogens to prevent their spread. TLRs are trans-
membrane proteins that present two principal domains, leucine-rich repeats (LRR) and a 
Toll/IL-1R (TIR), which recognize PAMPs and initiate signaling pathways, respectively. 
Currently, 15 mammalian Toll-like receptors are found (TLR1-15), of which 10 are in 
humans. TLR3, 7, 8, and 9 are intracellular receptors and the other ones are extracellular 
[59–61]. The binding partners of the recently discovered TLR10, TLR12, TLR13, and TLR15 
are unknown. TLR11 is only expressed in mice, and recent studies suggest that it associates 
with molecules originating from uropathogenic bacteria and Toxoplasma gondii [62, 63]. 
TLRs exert their functions through the formation of homo- or heterodimers. To date, five 
dimers have been described that are: TLR1/TLR2, TLR2/TLR6, TLR4/TLR4, TLR5/TLR5, 
and TLR10/TLR10 [64]. The TLR1/2 heterodimer recognizes bacterial triacyl lipopeptides, 
and TLR2/6 recognizes bacterial diacyl lipopeptides. In addition, each TLR in individual 
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form recognizes different ligands and induces the production of various cytokines and 
chemokines [65–67]. TLR1 and TLR2 recognize triacyl lipopeptides, TLR2 and TLR6 sense 
diacyl lipopeptides, lipoteichoic acid, and zymosan. Also, TLR2 recognizes peptidogly-
cans, lipoarabinomannan, porins, glycosylphosphatidylinositol-anchored mucin-like, and 
hemagglutinin. TLR3 recognizes double-stranded RNA, TLR4 senses LPS and envelope 
proteins. TLR5 recognizes flagellin, TLR7 and 8 can recognize single-stranded RNA and 
finally TLR9 recognizes DNA CpG and malaria hemozoin [68]. DCs show different expres-
sion levels of TLRs and respond dissimilarly to TLR ligands. The expression of TLRs varies 
with species, DC subtype, and maturation stage. All human TLRs are present in immune 
cells, specifically in DC, TLR1, 2, 3, 4, 7 and 9 have been shown to be present [69]. TLR10 
is not present in human dendritic cells; nevertheless, it has been recently demonstrated 
that this receptor could be found intracellularly in endosomes and can recognize dsRNA 
[70]. When TLRs bind their ligands (PAMPs), this (among another variables) can trigger 
changes in the maturation, migration, and actions of DC. This phenomenon initiates an 
inflammatory response characterized by the production of cytokines, cellular migration, 
and directly or indirectly the activation and generation of Th1, Th2, Th17, Treg, and even 
B lymphocyte responses [71].
2.2. RIG-I-like receptors (RLRs)
Retinoic acid-inducible gene-I-like receptors (RLRs) are intracellular receptors and, to this 
date, are a family of three members, which are RIG-I, melanoma-differentiation-associated 
gene 5 (MDA5), and laboratory of genetics and physiology 2 (LGP2). The ligand for RIG-I 
is RNA (5′ -PPP single-stranded RNA and short double-stranded RNA), MDA5 recognizes 
RNA (poly IC and long double-stranded RNA) and LGP2 recognizes RNA [72]. All three 
receptors are composed of a central DExD/H box helicase domain, which coordinates RNA 
binding and a C-terminal regulatory domain that is implicated in RNA binding. In addition, 
RIG-I and MDA5 contain two CARD domains (caspase activation and recruitment) that have 
critical signal activity and are involved in the innate immune and inflammatory responses 
upon RNA detection [73]. The activation of these receptors induces the production of type 
I IFN characterized by its antiviral and antibacterial activity; thus, RLRs are an important 
complement of the immune response, particularly, with intracellular pathogens, and could 
be important in the response against antigenic RNA from intracellular protozoa. It has been 
showed that RLRs responses are independent of TLRs responses [74].
2.3. NOD-like receptors (NLRs)
One important family of receptors found in DC is the nucleotide-binding oligomerization 
domain-containing receptors (NLRs), which are a family of 22 protein members in humans 
that can be classified into five subfamilies according to their structure: NLRA (CIITA), NLRB 
(NAIPs), NLRC (NOD1, NOD2 and NLRC3-5), NLRP (NLRP 1-14), and NLRX [74]. Their 
basic structure consists of a central nucleotide-binding domain (NBD), a carboxy-terminal 
leucine-rich repeats (LRR), and an amino-terminal effector domain. Some of the ligands that 
bind to these receptors are iE-DAP, MDP, RNA, ATP, bacterial toxins, uric acid, CPPD, amy-
loid-b, and anthrax lethal toxin [68]. NLRs are linked to different functions, as is the case of 
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NOD1, NOD2, CIITA, and NLRP10 that are signaling receptors and are associated to adaptive 
immunity. NLRC4 and NLRP3 are linked to the formation of the inflammasome and finally 
NLRP1, NLRP6, NLRP12, and NLRC5 participate both in signaling as well as in the formation 
of the inflammasome [75]. In relation to the formation of the inflammasome, NLRP 1, 2, 3, 6, 7, 
12, NLRC4/N, and AIP 2, 5 have been found to participate when those receptors sense PAMPs 
or DAMPs (damage-associated molecular patterns). Also, it has been documented that CIITA 
and NLRC5 can be activated by cytokines that lead to the transcription of MHC I and II, and 
NOD1-2 have TLR-like activity with the recognition of PAMPs and triggering of inflamma-
tory signaling cascades. Other members such as NLRP 2, 4, 6, 11, 12, NLRX1, NLRC3, etc. 
participate in the inhibition of the NF-κB pathways [76, 77]. Finally, NLRP 10 and 12 partici-
pate in cellular migration. In particular, NLRP10 plays a critical role in antigen-primed DC 
migration in draining lymph nodes [78], and NLRP-12 regulates migration of DC to a CCR7 
chemokine gradient, thus resulting in a reduced T cell response to antigen [79].
In conclusion, this large family of intracellular receptors can recognize viral, bacterial, proto-
zoan, and fungal antigens that trigger cellular innate and adaptive immune responses.
2.4. C-type lectin receptors (CLRs)
Myeloid cells, including DC and macrophages, express a large number of C-type lectin recep-
tors that are one of the most important PRRs that recognize carbohydrates [80]. They can 
have a transmembrane or soluble localization and can trigger phagocytic and inflammatory 
responses through the recognition of PAMPs, DAMPs, and tumor-associated molecular pat-
terns (TAMPs) [81]. The common structure in these receptors is the carbohydrate recognition 
domain (CRD), which can be found in different numbers and arrangements. They also pres-
ent an ITAM (immunoreceptor tyrosine-based activation) like motif or an ITIM (immunore-
ceptor tyrosine-based inhibition) motif [82]. A wide array of carbohydrates are recognized by 
CLRs, among those that can be found are high mannose glycans, mannose, mannosyl fatty 
acids, fucose glycans, Lewis antigens, glucans, among others. The recognition of the ligand 
by a CLR can activate or inhibit responses dependent or independent of the Syk signaling 
pathway [83]. This family of receptors has been classified according to their structure in 17 
groups that comprise almost 50 proteins. The groups that comprise the soluble receptors are: 
I (proteoglycans), III (collectins), VII (free CTLD), IX (tetranectin), and XII (CTLD/acidic neck). 
On the other hand, transmembrane receptors are grouped as follows: II (type 2 receptors), IV 
(selectins), V (NK cell receptors), VI (MMR), X (polycystin), XI (attractin), and XIV (endosialin) 
[82]. Several CLRs are present in DC and the best characterized are DCIR, DCSIGN (CD209), 
Dectin1, Langerin, and MMR (CD206). Langerin (CD207) on LC in the epithelial layer of the 
skin has unique carbohydrate specificity for high mannose and LeY carbohydrates and is 
involved in the recognition of various viruses [84]. DEC 205 has extensively been employed 
for target delivery of antigens to DC in murine and human studies [16]. It has been shown that 
targeting antigen to the DEC205 receptor improves humoral and cellular immune responses 
when DC are stimulated with activating agents or adjuvants such as poly I:C [85]. In mice, 
this receptor is expressed on cortical thymic epithelium, thymic medullary DC (CD11c+, 
CD8α+), and subsets of peripheral DC (splenic, lymph node DC, dermal, interstitial DC, and 
Langerhans cells) [86]. In contrast, DC-SIGN (CD209) is merely expressed on moDCs and 
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on CD14+ dDCs in dermal layers of the skin and has specificity for mannose and all Lewis 
type carbohydrates (Lewis A, B, X, and Y) [87]. This receptor is often endosialin with the 
MR (CD206) and shares mannose specificity [88]. DCIR (for DC immunoreceptor) (CLEC4a) 
has broad carbohydrate specificity for mannose and fucose [89, 90] and has been shown to 
participate in T cell responses. Different from other CLRs, DCIR contains an ITIM motif and, 
upon triggering with Abs, inhibits the production of inflammatory cytokines and, thus, has 
been associated with homeostatic control and control of inflammation [91–93]. Also, it has 
been shown that DCIR can participate in the capture of HIV-1 and promote infection in trans 
and in cis of autologous CD4+ T cells from human immature monocyte-derived DCs [94].
Finally, these receptors can recognize (and opsonize) pathogens and the responses to these 
events are phagocytosis for antigen uptake, cell migration, cell adhesion, inhibition of 
cytokine production, and interaction between DC and T lymphocytes [95]. In conclusion, 
CLRs are key participants in the immune response that spot important signals of PAMPs, 
DAMPs, and TAMPs with which immune cells (e. g., dendritic cells) sense and recognize 
the environment. Its interactions and intersections trigger, adapt, and regulate immune 
responses [96].
In addition to the PRRs just mentioned, it is important to note that some orphan receptors 
have been described for which a ligand has not been found, as well as the family of ALR 
intracellular receptors (AIM2-like receptors) and another family of lectins (I-lectins) Siglecs 
(sialic acid binding Ig-like lectins) [97].
3. Role of dendritic cells in the infection with parasites
Due to a wide variety of functions that dendritic cells display both in the innate immune 
response as well as in the adaptive immune response, they are key participants in the defense 
against parasites. DC have the capacity to recognize different molecules in the surface of para-
sites and are efficient phagocytes; thus, several intracellular parasites reside inside DC. Once 
DC phagocytose intracellular parasites, they can exert their microbicidal capacities, although 
it has been shown that they are not as efficient in the destruction of microorganisms as other 
phagocytes such as macrophages and neutrophils. Once internalized, DC process antigens 
for presentation to T cells. DC have the unique property to migrate to regional lymph nodes 
where they activate naïve T cells, as well as produce cytokines and participate in the modula-
tion of the immune response, the amplification of the innate immune response, and can also 
participate in immunological tolerance.
Protozoan infections that persist in urban environments including leishmaniasis, Chagas 
disease, malaria, and zoonotic diseases such as toxoplasmosis are a matter of great concern 
due to their prevalence, morbidity, and mortality [98]. Our best hope to counteract them is 
the development of new and innovative technologies. For this development, the better under-
standing of the biology of these parasites and their interaction with their host is of outmost 
importance. We chose the above-mentioned diseases and analyzed their interaction with DC 
that are one of the most important participants of the immune response.
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3.1. Interaction of dendritic cells with Leishmania
3.1.1. Generalities of Leishmania
Leishmania is an obligate intracellular parasite that presents two morphological stages: the 
flagellated promastigote that is found in the salivary glands of the insect vector and the 
aflagellated amastigote that is the intracellular form found in the vertebrate host. This genus 
of parasites is constituted by diverse species that are morphologically indistinguishable and 
are grouped in three subgenera: Leishmania, Viannia, and Sauroleishmania. The species that 
cause infection in humans and other mammals are found in the subgenus Leishmania and 
Viannia. Sauroleishmania has been only found to infect some reptiles. Species belonging to 
Leishmania are characterized for having a suprapyloric development and among these are: 
donovani, chagasi (infantum), major, tropica, aethiopica, mexicana (pifanoi), amazonensis, and ven-
ezuelensis. On the other hand, the species of the subgenus Viannia have a peripyloric develop-
ment and are braziliensis, guayanensis, peruviana, and panamensis. Leishmania is transmitted by 
Diptera belonging to the family Psychodidae, specifically, by females of the genus Lutzomyia 
and Phlebotomus [99, 100]. Lutzomyia is the transmitter of leishmaniasis in America, and 
Phlebotomus transmits this pathology in Africa, Asia, and Europe [101, 102].
3.1.2. Leishmania life cycle
Leishmania life cycle starts when the insect vector feeds blood from the vertebrate host and 
inoculates promastigotes in the superior dermis [103]. Then, promastigotes are recognized 
through different receptors such as CR3 [104], C-type lectin receptors, and FcγR and are 
phagocytosed by dermal macrophages, where they transform to amastigotes [105] and also 
infect neutrophils. Thanks to a series of events such as the inhibition of phagocytosis, resis-
tance to microbicidal mechanisms, and inhibition of host cells apoptosis, amastigotes manage 
to survive inside macrophages and duplicate until they lyse them and infect new surrounding 
cells, such as dendritic cells. If the parasite is not able to inhibit the different microbicidal 
mechanisms of macrophages, they will be able to destroy them mainly through the produc-
tion of nitric oxide and induce the activation and recruitment of proinflammatory cells such as 
cutaneous mast cells, neutrophils, and inflammatory monocytes that lead to the development 
of a focus of chronic inflammation in the site of infection, which will be evident in the patient 
[105, 106]. The female sand fly when ingests blood from an infected host draws infected cells 
as well as free amastigotes and in this form the life cycle continues.
3.1.3. Interaction of Leishmania major with macrophages and DC
One of the most studied interactions of DC with a parasite is the interaction with the intracel-
lular parasite Leishmania. In the murine model of infection and using Leishmania major, it has 
been shown, as already mentioned, that promastigotes infect macrophages and neutrophils 
that are localized near the site of inoculation. Promastigotes are phagocytosed by macro-
phages mainly through CR3 [104], which permits parasites to enter to this host cell without 
activating it [107]. Interestingly, the infection with Leishmania downregulates the capacity of 
macrophages to produce IL-12. Even the stimulation of macrophages with IFN-γ/LPS does not 
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elicit the production of IL-12 when cells are infected with L. major [108]. Once promastigotes 
enter to macrophages without activating them, they differentiate into amastigotes and start 
dividing in the parasitophorous vacuoles. Then, amastigotes are released to the extracellu-
lar milieu where they are phagocytosed by neighboring cells such as DC. DC phagocytose 
amastigotes mainly through FcγRI and FcγRIII, inducing DC maturation, migration to lymph 
nodes, and IL-12 production [109]. It has also been shown that Leishmania-infected DC upregu-
late the levels of costimulatory molecules such as CD40, CD54, CD80, and CD86, as well as of 
MHCII; that is, the maturation of DC enables them to initiate the activation of T lymphocytes 
[110]. Other authors have demonstrated that during the course of chronic infection of C57BL/6 
mice with L. major, the main producers of iNOS are inflammatory DC, which are recruited 
in a CCR2-dependent manner and the induction of iNOS depends on the development of a 
local Th1 microenvironment [111]. In addition to the analysis of the infection of murine DC 
with L. major, other authors have shown that in the case of human DC infected with L. major 
metacyclic promastigotes, the production of high amounts of IL-12 needs the interaction of 
CD40-CD40L, although infected DC are able to produce some IL-12. Also, the infection of 
human DC with L. major promastigotes does not inhibit the process of maturation [112].
3.1.4. Role of DC in the adaptive immune response against Leishmania major
Once DC capture Leishmania parasites, they migrate to the lymph nodes were they activate 
naïve CD4 and CD8 T lymphocytes in order for them to respond specifically against the 
parasite with an immune response dominated by the presence of IFN-γ and cytotoxic T 
lymphocytes species specific in what has been called a type Th1/Tc1 immune response. This 
type of response permits mice to control infection and eliminate the parasite [113]. IL-12-
producing DC have been observed until week 4 postinfection with a peak in week 6 just 
before the Th1/Tc1 IFN-γ-producing response develops completely [114]. Nevertheless, the 
reason for the delay in DC maturation still remains to be clarified. Iborra and colleagues 
have described a route that attempts to understand this delay in the maturation of DC after 
Leishmania infection. They found that L. major parasites secrete a soluble factor that binds to 
the soluble macrophage c-type lectin receptor (Mincle) of DC, which inhibits its maturation. 
They showed that Mincle deficiency favored stronger DC activation represented by a higher 
expression of costimulatory molecules, migration to dLNs and priming of a Th1 response. 
Thus, mice deficient in Mincle receptor are capable of controlling parasite replication and 
indeed had smaller lesions [115]. It has been shown that in the infection of mice with L. major 
metacyclic promastigotes, Langerhans cells induce the activation of regulatory T lympho-
cytes [116]. Murine CD103+ dermal DC have been shown to be responsible of inducing a 
protective immune response against L. major since mice lacking this DC subtype develop an 
immune response dominated by regulatory and Th2 lymphocytes infection [117].
3.1.5. Interaction of DC with L. mexicana
While L. major is an etiologic agent of cutaneous leishmaniasis (CL) in the Mediterranean 
region, L. mexicana is in Mexico and Central America. Although both species cause CL, the 
case of L. mexicana is of particular interest due to the fact that this species can cause localized 
cutaneous leishmaniasis (LCL) and diffuse cutaneous leishmaniasis (DCL). Different studies 
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have shown that the interaction of L. mexicana and its principal host cells, macrophages and 
DC, are substantially different as compared to what has been observed with the L. major 
model. It has been observed that in DC infected with L. mexicana, the parasite manages to be 
internalized without the initiation of cell maturation or the production of IL-12. Although the 
infection inhibits IL-12 production, L. mexicana does not eliminate the capacity of DC to pro-
duce it and, indeed, when an external stimulus such as LPS is used, infected DC are capable 
of producing and secreting IL-12. In addition it was observed that the internalization of the 
parasite is independent of opsonization [118]. In relation to the recognition of L. mexicana by 
DC, the information about the receptors involved is scarce. On one hand, it has been reported 
that DC-SIGN is capable of binding L. mexicana LPG [119]. Recently, our group showed that 
DC-SIGN participates in an important manner in the internalization of L. mexicana promasti-
gotes since the blockade of the receptor with a specific antibody diminished significantly the 
interaction of monocyte-derived dendritic cells with L. mexicana promastigotes [120]. Using 
the same strategy of blocking DC-SIGN with an antibody, its role in the infection of DC with 
L. pifanoi amastigotes was shown to be relevant since it dramatically diminished the interac-
tion of DC with amastigotes [121].
3.1.6. Interaction of DC with other species of Leishmania
It has been observed that DC can interact with both L. infantum y L. pifanoi amastigotes and 
promastigotes through DC-SIGN and that it binds more avidly the infective metacyclic forms. 
Interestingly, the interaction of DC with L. major metacyclic promastigotes does not depend 
on DC-SIGN [122]. Also, it has been shown that plasmacytoid DC do not internalize L. infan-
tum promastigotes, although contact of the parasites with these cells induces the secretion of 
IFNα/β, but not of IL-12 [123]. Also, it has been described that in the early stages of Leishmania 
infection, the inflammatory milieu that is produced is ideal for the induction of monocytes 
toward Tip-DC.
3.1.7. Molecular mechanisms involved in the modulation of DC by Leishmania
The molecular mechanisms involved in the modulation of DC during the infection with 
Leishmania have not been fully analyzed. In the murine model of infection with L. major, it has 
been clearly established that susceptible mice (Balb/c) mount a Th2-type response that enables 
them to eliminate the parasite while resistant mice (C57/BL6) mount a Th1 response that 
permits the elimination of the parasite. In contrast, C57/BL6 mice infected with L. mexicana 
metacyclic promastigotes do not resolve infection and it becomes chronic, what has been asso-
ciated with a decrease in the recruitment of monocytes, a reduction in inducible nitric oxide 
synthase (NOS2) synthesis in moDC along with a reduction in the migration to the lymph 
node, which results in an insufficient activation of a Th1 response [124]. Leishmania parasites 
possess an extraordinary capacity to manipulate host cells. In particular, it has been shown 
that the infection of murine DC with L. mexicana promastigotes rapidly affects DC molecular 
mechanisms necessary for the development of a protective immune response, among them, 
an increase in tyrosine phosphatases, which translates in an inactivation of mitogen-activated 
protein kinases (MAPK), and decrease in the translocation of transcription factors such as 
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NF-κB and AP-1. In addition, parasites also modulate DC maturation markers decreasing the 
surface expression of antigen-presenting and costimulatory molecules [125]. Our group has 
worked for several years in the modulation of DC by L. mexicana. We have shown that LPG 
purified from L. mexicana promastigotes induces a major secretion of IL-12 and NF-κB trans-
location in human DC as compared with monocytes [126]. We also showed that the infection 
of murine DC with L. mexicana amastigotes downregulates NOS2 and thus diminishes NO 
production [127]. On the other hand, we have also shown that the infection of human DC with 
L. mexicana amastigotes and promastigotes inhibits the activation of MAPK JNK and p38, and 
the infection of human DC with L. mexicana amastigotes activates AKT during camptothecin-
induced apoptosis [128, 129].
In addition to the modulation of DC biology exerted by Leishmania that has just been 
described, another intracellular parasite whose interaction with DC has been deeply studied 
is Toxoplasma gondii.
3.2. Dendritic cells in the infection with Toxoplasma gondii
3.2.1. Generalities of T. gondii
Toxoplasma gondii is an intracellular parasite that causes toxoplasmosis, and it can be hosted 
by diverse warm-blooded animals and is present in two interconvertible stages: the lytic, 
invasive, and active tachyzoites and the slow-growing, encysted bradyzoites. The oocysts 
present in the definitive host, a feline, are highly infective and long-lived and are shed in the 
feces for a limited time [130]. The infection initiates with direct contact with oocysts or by 
consumption of undercooked meat containing bradyzoite cysts. Bradyzoite cysts convert to 
tachyzoites in the small intestine of the intermediate host and can infect almost all nucleated 
cells. Here, they replicate within a parasitophorous vacuole (PV), egress by lysing the cell, 
and infect neighboring cells. Tachyzoites elicit a potent immune response that eliminates most 
parasites. However, some tachyzoites can evade this response, convert back to bradyzoites, 
and persist mostly in nonreplicative cells such as those in the brain or heart of their intermedi-
ate host [131].
3.2.2. Immune response to T. gondii
Toxoplasma orchestrates a carefully balanced string of events between various cell types 
including neutrophils, DCs, and macrophages upon first encountering the host innate 
immune defense. A complex network of molecular signaling pathways leads to the activa-
tion and regulation of cytokines and ultimately to the production of effector molecules [132]. 
Acquired resistance to T. gondii infection is mediated by a mucosal and systemic Th1 cellular 
immunity [133]. The deviation to a Th1 response depends enormously on the production of 
IL-12 by different cells such as conventional DCs, macrophages, and pDCs. Parasite infection 
causes damage to the intestinal epithelium resulting in the translocation of microflora and 
subsequent MyD88-dependent signaling and IL-12 production. IL-12 triggers the prolifera-
tion of NK cells, CD4 T cells, and CD8 T cells, which mediate cytotoxicity and the production 
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of high amounts of IFN-γ [134, 135]. It has been previously showed that DC pulsed with T. 
gondii antigens elicit protective immunity against chronic toxoplasmosis in mice [136, 137].
3.3. Interaction of DC with T. gondii
3.3.1. Recognition of T. gondii by DC
DC are crucial participants in the immune response against T. gondii and one of the leading 
roles that they play in the production of IL-12, which, as previously mentioned, promotes 
the production of IFN-γ and thus deviates the immune response toward a Th1. DC recognize 
diverse T. gondii molecules; in particular, it has been shown that a soluble parasite extract 
(STAg) has a major capacity of eliciting IL-12 from splenic DC as compared to other PAMPs 
such as LPS and CpG oligonucleotides [138]. The production of IL-12 induced by T. gondii 
in DC is dependent on MyD88, an adaptor molecule in TLR signaling pathways, and the 
chemokine receptor CCR5, since the production of IL-12 decreases dramatically in mice lack-
ing MyD88 or CCR5 [139]. Interestingly, CCR5 in DC is induced with cyclophilin-18 from T. 
gondii [139]. The participation of MyD88 in the induction of IL-12 by T. gondii presupposes the 
recognition by TLRs. Indeed, it has been shown a profilin-like protein, which is not required 
for the intracellular growth of T. gondii, but is indispensable for host cell invasion and active 
egress from cells [139], was identified as a ligand of TLR11 and the profilin-like protein is 
also recognized by TLR-12 [62], and is critical for IL-12 production, especially in plasmacy-
toid DCs (pDCs) [140]. TLR11 has been localized intracellularly associated with the nucleic 
acid-sensing TLR trafficking protein UNC93B1.52. A mutation in this protein impedes TLR 
intracellular trafficking, which has been shown to cause a reduction in IL-12 production in 
mice infected intraperitoneally with Toxoplasma bradyzoites and increases susceptibility to 
infection [141, 142].
Both cyclophilin-18 and the profilin-like protein stimulated IL-12 production in CD8α+ DC 
and CD8α− DC. Although humans do not express either TLR11 or TLR12, human monocytes 
produce proinflammatory cytokines in response to T. gondii infection, suggesting that other 
TLRs in humans recognize different compartments of T. gondii to produce IL-12 in antigen-
presenting cells. Additionally, DC also produce chemokines such as CCL2 and CXCL2 upon 
recognition of parasite components including virulence factors [143]. These chemokines 
induce the migration of Ly6ChighCCR2+ monocytes and neutrophils to the infection site [144]. 
Albeit not demonstrated specifically in DC, other TLRs, such as TLR2, can also be activated 
in response to Toxoplasma [145]. TLR2 and TLR4 both signal after binding Toxoplasma gly-
cosylphosphatidylinositol (GPI) anchors [146]. However, single absence of either TLR2 or 
TLR4 in DC did not reduce the production of IL-12 in response to STAg [147].
3.3.2. Effector functions of DC against T. gondii
It is possible that DCs can directly act as effector cells to eliminate Toxoplasma as suggested 
by their ability to display oxygen-dependent microbicidal activity after IFN-γ activation 
[148]. Moreover, plasmacytoid DCs (pDCs) have been shown to be efficient at autophagy 
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[149], a process known to eliminate Toxoplasma in primed macrophages and to involve the 
family of p47 GTPases [150]. The various subsets of DC possibly recognize either direct 
infection with Toxoplasma or sense parasite products differently, and are thus important 
mediators of parasitic elimination and facilitators for the development of an efficient adap-
tive immune response. Conventional CD11c+ DC have been shown to play key roles in host 
resistance to Toxoplasma bradyzoite cysts administered i.p. [151, 152].
3.4. Role of DC in the infection with Plasmodium
3.4.1. Plasmodium life cycle
Malaria is a disease caused by the blood protozoan of the genus Plasmodium about which 
there have been described five species capable of infecting humans that are P. falciparum, P. 
vivax, P. malariae, P. knowlesi, and P. ovale [153]. The life cycle of this parasite starts when a 
hematophagous female mosquito of the genus Anopheles introduces its proboscis, containing 
infective sporozoites into the mammalian host. There is evidence that once the sporozoites 
have been inoculated, they can remain on the skin for hours and slowly release into the blood 
[154, 155]. Once sporozoites reach the bloodstream, they migrate to the liver where they infect 
hepatocytes and transform into merozoites that infect red blood cells. Some of these mero-
zoites transform into male and female gametocytes to finally complete their cycle within the 
mosquito’s digestive tract [156, 157].
3.4.2. Interaction of DC with Plasmodium
Several studies have revealed that DC play an important role during Plasmodium life cycle, 
as well as in the pathophysiology and outcome of the disease. Although Plasmodium does 
not infect DC, it has been shown that the interaction of DC with infected erythrocytes has 
an effect on DC functions. In particular, it has been shown that erythrocytes infected with P. 
falciparum and co-cultured with human DC manage to induce in them an arrest in the process 
of maturation, thus inhibiting their ability to stimulate and activate T lymphocytes; however, 
the effect is dependent on the parasite: DC ratio [158, 159]. Also, during the acute phase of 
infection with Plasmodium, there is an increase in BDCA3+ DC, but not in CD1c+ DC, which 
correlates with a severe presentation of the disease [160, 161]. Other DC populations that 
change during Plasmodium infection are pDC (HLA-DR+CD123+): mDC (HLA-DR+CD11c+). 
It has been reported that the ratio of pDC:mDC diminishes in patients suffering from the 
acute phase of P. vivax infection. In addition to this decrease, there also exists an arrest in 
DC maturation demonstrated by a reduction in CD86 in patients infected with P. vivax and 
a decrease in CD83 and HLA-DR in individuals in the acute phase of infection with P. vivax 
and P. falciparum. This diminution of CD functions in these infections is accompanied by an 
increase in the number of cells that die by apoptosis, as well as by the decrease in their ability 
to capture, mature, and present antigens to T cells [162–164].
Other research groups have addressed the role of DC in the induction of the response of 
T and B cells in Plasmodium infection. It has been shown that TCD8+ cells, previously acti-
vated by DC, exert their cytotoxic effect by inducing death of P. vivax sporozoites housed in 
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hepatocytes, thus, reducing parasite loads in hepatocytes. There is evidence that suggests 
CD8+CD11b-DC located in the peripheral lymph nodes near the mosquito inoculation site are 
the same subtype of DC responsible for the activity of TCD8+ cells [165–168]. The protective 
response of TCD8+ cells is associated with the production of IFN-γ, which is induced by two 
subtypes of mature (CD40+) spleen DC and (CD8α+CD11b− and CD8α−CD11b+) D C) [169, 170]. 
There is evidence that, of these two subtypes, only the CD8α−CD11b+ DC are responsible for 
the activation of TCD4+ cells, in the acute phase of the infection, while the CD8α+CD11b−DC 
participate in the process of antigen cross presentation throughout the infection [171, 172]. In 
relation to the activation of TCD4+ cells, in different study models, it has been shown that the 
presentation of Plasmodium antigens by DC to TCD4+ cells expresses MHC-II, CD40, and CD80 
and produces IL-12, IL-6, and TNF-α, thus inducing TCD4+ cells to express IL-2, IFN-γ, and 
TNF-α. Finally, the stimulation of DC with Plasmodium antigens also induces their migration 
of DC to lymphoid organs [173–177].
Apart from the interaction of DC with protozoan parasites that has been discussed, we chose 
Trichinella spiralis as an example of the interaction of a helminth with DC.
3.5. Interaction of Trichinella spiralis with DC
Trichinella spiralis is a parasitic helminth that belongs to the group of nematodes. Its biological 
cycle begins when a mammal (usually mouse, rat, pig, and human) ingests raw or undercooked 
meat containing cysts (encysted larvae). As it passes through gastric acid and pepsin, the larva 
is released from the cyst and invades the mucosa of the small intestine, where it matures to 
the sexually differentiated adult state that initiates reproduction [178]. After 1 week, females 
release larvae, which migrate to skeletal striated muscle where they encyst and the cycle closes 
when cysts are ingested by another mammal [178]. In order for T. spiralis to remain for long 
periods in the muscle, the parasite must have mechanisms to evade the immune response and 
inhibit tissue inflammation. It has been described that T. spiralis muscle larvae have structural 
carbohydrates on their surface that contribute to the activation of the immune response that 
results in Th2/anti-inflammatory response [179]. It has been shown that T. spiralis glycans affect 
the anti-inflammatory environment and can interfere with the development of inflammatory 
diseases [180]. On the other hand, T. spiralis muscle larvae excrete a molecular complex called 
excretory-secretory antigen (ES L1) that has been shown to alter DC maturation [180]. In addi-
tion, immature DC resulting from the exposure to ES L1 induce a Th2 and regulatory response 
with the production of IL-10 and TGF-β, but without increasing CD4+CD25+Foxp3+ effector T 
cell population [179]. Thanks to these two mechanisms, the induction of an anti-inflammatory 
response and the inhibition of DC maturation, T. spiralis survives as long as it is the muscular 
larva without inducing inflammation or an adequate immune response.
4. Conclusion
Dendritic cells represent a wide constellation of cells that perform crucial roles in the immune 
response covering from recognition and phagocytosis, to antigen processing and presentation 
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to naïve T cells and immune tolerance. Due to this wide array of functions, they constitute a 
bridge that connects the innate immune response with the adaptive and are very important 
against parasites. DC are able to recognize diverse PAMPs present in parasites through dif-
ferent PRRs such TLRs, CLRs, NLRs, and RLRs, some of which, upon binding their respective 
ligand, induce phagocytosis and/or signal for the production of different molecules. Parasitic 
infections cause great morbidity and mortality. For the majority of them, there are no vac-
cines and the treatments that are not always effective. The better understanding and gaining 
of knowledge on the biology of parasites and their interaction with the immune system, in 
particular with DC due to the important role that play in the immune responses, will permit 
the development of new strategies and drugs to effectively treat the pertaining diseases men-
tioned in this work.
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